Fully agree. It needs to be a capital light setup with expanding use cases for pain management. I definitely think the product can stand on its own feet, the question is can they generate scale through these use cases which I believe is very possible. Slim down the core business and focus on marketing and influencing the right levels for mass distribution and get some good partners
Ann: MVP Announces $10M Capital Raise, page-18
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.005(1.11%) |
Mkt cap ! $51.25M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.0¢ | 44.0¢ | $19.9K | 44.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 44643 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.57pm 08/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |